These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31603994)

  • 1. The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures.
    Adaszewska A; Kalińska-Bienias A; Jagielski P; Woźniak K; Kowalewski C
    J Cutan Pathol; 2020 Feb; 47(2):121-127. PubMed ID: 31603994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
    Venkataswamy C; Vinayagam N; Shanmugasundaram S; Rai R
    J Cutan Pathol; 2023 Mar; 50(3):259-265. PubMed ID: 36444506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
    Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
    J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
    Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
    JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid.
    Esmaili N; Mortazavi H; Kamyab-Hesari K; Aghazadeh N; Daneshpazhooh M; Khani S; Chams-Davatchi C
    Clin Exp Dermatol; 2015 Apr; 40(3):324-30. PubMed ID: 25476471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
    Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
    Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.
    van Beek N; Rentzsch K; Probst C; Komorowski L; Kasperkiewicz M; Fechner K; Bloecker IM; Zillikens D; Stöcker W; Schmidt E
    Orphanet J Rare Dis; 2012 Aug; 7():49. PubMed ID: 22876746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochip technology for the serological diagnosis of bullous pemphigoid.
    Zarian H; Saponeri A; Michelotto A; Zattra E; Belloni-Fortina A; Alaibac M
    ISRN Dermatol; 2012; 2012():237802. PubMed ID: 23346412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature.
    Yang A; Xuan R; Murrell DF
    Australas J Dermatol; 2019 Aug; 60(3):e173-e177. PubMed ID: 30968398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.
    Damoiseaux J; van Rijsingen M; Warnemünde N; Dähnrich C; Fechner K; Tervaert JW
    J Immunol Methods; 2012 Aug; 382(1-2):76-80. PubMed ID: 22580378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology.
    van Beek N; Krüger S; Fuhrmann T; Lemcke S; Goletz S; Probst C; Komorowski L; Di Zenzo G; Dmochowski M; Drenovska K; Horn M; Jedlickova H; Kowalewski C; Medenica L; Murrell D; Patsatsi A; Geller S; Uzun S; Vassileva S; Zhu X; Fechner K; Zillikens D; Stöcker W; Schmidt E; Rentzsch K
    J Am Acad Dermatol; 2020 Nov; 83(5):1315-1322. PubMed ID: 32004645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
    Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients.
    Yang A; Xuan RR; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro JM; Mahmoudi H; Patsatsi A; Drenovska K; Vassileva S; Murrell DF
    J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2327-2333. PubMed ID: 31325388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.